Mark Warner (D-VA)

Health CARE Act of 2026

S. 5496 · Senate bill Health

A Democratic bill with no cosponsors

Last activity — Read twice and referred to the Committee on Finance.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

The Health CARE Act of 2026 aims to expand access to and lower the cost of healthcare across the United States. It creates a new low-cost health plan available through exchanges starting in 2028 and extends enhanced health insurance tax credits. The bill expands Medicare drug price negotiation limits, caps out-of-pocket prescription drug costs at $2,000 for group and individual health plans, and caps monthly insulin cost-sharing at $35. It strengthens price transparency requirements for hospitals, clinical laboratories, imaging providers, and ambulatory surgical centers. Finally, the legislation reforms pharmacy benefit managers, prevents abusive spread pricing in Medicaid, and adds hearing care coverage to Medicare.

Yes· 3 of 27

  • Scored +9

    Does this lower the price of prescription medicines?

    The bill caps out-of-pocket prescription drug costs at $2,000, caps monthly insulin prices at $35, and expands Medicare drug price negotiation.

  • Scored +8

    Would people over 65 be better off under this?

    Seniors gain coverage for hearing aids and audiology services under Medicare, alongside prescription drug price protections.

  • Scored +8

    Would households on low incomes be better off under this?

    Low-income households benefit from enhanced Medicaid support during economic downturns and permanently extended health insurance tax credits.

The opposite

  • Scored -2

    Would business owners be better off under this?

    Business owners face increased regulatory compliance burdens and reporting requirements regarding group health plans.